The 2027 FDA ISPE Compounding Quality Center of Excellence Conference will bring together outsourcing facilities, pharmacy compounders, regulators, healthcare providers, suppliers, and other industry professionals to advance quality, safety and access across the compounding industry. This conference is co-sponsored by the U.S. Food and Drug Administration and the International Society for Pharmaceutical Engineering.
This two-day hybrid conference will offer in-person and virtual participation. Attendees will hear to regulatory updates, emerging industry trends, compounding best practices, and practical insights into current good manufacturing practice requirements. The comprehensive conference experience will feature keynote presentations, concurrent education sessions, panel discussions, continuing education opportunities, and engagement with FDA and industry experts. In-person participants will also benefit from dedicated networking opportunities and a welcome reception designed to foster collaboration, strengthen partnerships, and encourage the exchange of ideas across the compounding community.
